BIOCORYL 100 MG/ML

Cognitive & Mental Function; Anticude is a medicine that is used as an antidote to curing agents, including synthetic curing agents, including synthetic ones, in prolonged apnoea and in any syndrome involving any syndrome involving atony of the striated or smooth fibre musculature striated or smooth fibre ...

Biocoryl is indicated for the treatment of potentially malignant ventricular arrhythmias in adults over 18years of age.This medicinal product is administered parenterally (intramuscularly or intravenously). The intravenous route should be reserved for emergencies.

Syner-KINASE® is indicated for the lysis of blood clots in the following conditions: - thrombosed intravascular catheters and cannulae - extensive acute proximal deep vein thrombosis - acute massive pulmonary embolism - acute occlusive peripheral arterial disease with limb threatening ischemia

Anticude is a medicine that is used as an antidote to curing agents, including synthetic curing agents and synthetic ones, in prolonged apnea and in any syndrome involving atony of the striated or smooth fibre musculature. It is also used in the diagnosis and treatment of myasthenia gravis and to aid in th...

Syner-KINASE® is indicated for the lysis of blood clots in the following conditions: - thrombosed intravascular catheters and cannulae
- extensive acute proximal deep vein thrombosis
- acute massive pulmonary embolism
- acute occlusive peripheral arterial disease with limb threatening ischemia

Syner-KINASE® is indicated for the lysis of blood clots in the following conditions: - thrombosed intravascular catheters and cannulae
- extensive acute proximal deep vein thrombosis
- acute massive pulmonary embolism
- acute occlusive peripheral arterial disease with limb threatening ischemi...

Syner-KINASE® is indicated for the lysis of blood clots in the following conditions: - thrombosed intravascular catheters and cannulae
- extensive acute proximal deep vein thrombosis
- acute massive pulmonary embolism
- acute occlusive peripheral arterial disease with limb threatening ischemia

Since the end of 2020, Mana Pharma, S.L. has played a key role in the distribution of Medicines for Special Situations (MSS) in Spain, contributing, in agreement with the Health Authorities, to alleviate the lack of supply of medicines that occur in our country.